ELTX vs V · $132.3M cap vs P/E 33, rev $40.00B
Elicio Therapeutics Inc. (ELTX) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported ELTX revenue for 2023-03-31 was $0. Net income was -$8.0M. Revenue was down 100.0% from 2022-12-31 to 2023-03-31. ELTX currently screens at market cap $132.3M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
ELTX currently screens at market cap $132.3M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the ELTX and V stock pages for the full models.
Not investment advice.